Consolidated Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7539631

Concept 2023-04-01 to
2023-09-30
2022-04-01 to
2022-09-30
Consolidated statement of income
Statement of income
Net sales
44,000 JPY
179,000 JPY
Cost of sales
11,000 JPY
44,000 JPY
Operating expenses
Selling, general and administrative expenses
550,603,000 JPY
805,202,000 JPY
Operating expenses
Ordinary profit (loss)
-551,566,000 JPY
-809,792,000 JPY
Gross profit (loss)
33,000 JPY
134,000 JPY
Operating profit (loss)
-550,569,000 JPY
-805,068,000 JPY
Net sales
Operating expenses
Research and development expenses
363,891,000 JPY
643,726,000 JPY
Non-operating income
193,000 JPY
557,000 JPY
Interest income
6,000 JPY
11,000 JPY
Non-operating income
Other
186,000 JPY
546,000 JPY
Cost of sales
Selling, general and administrative expenses
Non-operating expenses
Other
JPY
61,000 JPY
Non-operating expenses
1,190,000 JPY
5,281,000 JPY
Share issuance costs
JPY
1,073,000 JPY
Extraordinary losses
1,406,000 JPY
JPY
Impairment losses
1,406,000 JPY
JPY
Profit (loss) before income taxes
-552,972,000 JPY
-809,792,000 JPY
Gross profit
Income taxes - current
950,000 JPY
950,000 JPY
Extraordinary losses
Income taxes
950,000 JPY
950,000 JPY
Profit (loss)
-553,922,000 JPY
-810,742,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.